Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study

BACKGROUND: Weight gain early after transplant is a risk factor for posttransplant metabolic syndrome (PTMS), cardiovascular events, and renal insufficiency. The impact of mammalian target of rapamycin inhibition on posttransplant weight gain and the development of PTMS components postliver transpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Charlton, Michael, Rinella, Mary, Patel, Dharmesh, McCague, Kevin, Heimbach, Julie, Watt, Kymberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Clinical Science—Liver
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704647/
https://www.ncbi.nlm.nih.gov/pubmed/28817434
http://dx.doi.org/10.1097/TP.0000000000001913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704647/
https://www.ncbi.nlm.nih.gov/pubmed/28817434
http://dx.doi.org/10.1097/TP.0000000000001913

Ejemplares similares